RTEL1 and dyskeratosis congenita: This work provides an example of the importance of the careful balance of PAR synthesis and degradation and also provides an attractive therapeutic option for RTEL1-mediated telomeropathies, such as Hoyerall–Hreidarsson syndrome (HHS) and Dyskeratosis congenita (DKC) [152–156].